FDA Inspection 1075688 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on Dec 11, 2018 in Alexandria, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 11, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Alexandria, LA (United States)